Utilization of Caplacizumab in the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)

In this episode, we discuss the mechanism , contraindications, dose, and other considerations in the use of Caplacizumab for TTP

Episode metadata supplied by the publisher feed · Published Nov 19, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Utilization of Caplacizumab in the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)

0:00 7:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 7 minutes long.

This episode was published on November 19, 2021.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!